论文部分内容阅读
肝炎中抗－ＥＢＶ－ＩｇＭ检测的临床意义太原市传染病医院（０３００１２）陈秀纬，王雪芳，荀健，邸秀珍，齐改梅山西医学院第一附属医院赵龙凤为了探讨抗－ＥＢＶ－ＩｇＭ在肝炎中的确切意义，我们用免疫酶法对急、慢性肝炎患者，进行了抗－ＥＢＶ－ＩｇＭ的检测，并观察了小儿抗－ＦＢＶ－ＩｇＭ阳性组与其阴性组患者的病情之间相互影响，现报告如下：资料与方法１９９０年１月至１１月间，我院收治９５５例急、慢性病毒性肝炎中，６１２例，成人４９０例，小儿（１４岁以下者）１２２例，入院后取血用免疫酶法检测抗－ＥＢＶ－ＩｇＭ。试剂由中国预防医学科学院病毒学研究所肝炎室提供。结果一、抗－ＥＢＶ－ＩｇＭ阳性率：６１２份血清标本中，抗－ＥＢＶ－ＩｇＭ阳性１２８例，占２０．９％，其中成人４９０例血清标本中，抗－ＥＢＶ－ＩｇＭ阳性７４例，占１５．１％；小儿１２２例血清标本中，抗－ＥＢＶ－ＩｇＭ阳性５４例，占４４．３％，小儿抗－ＥＢＶ－ＩｇＭ阳性率明显高于成人（／２＞６．６２，Ｐ＜０．０１）。二、小儿不伴有抗－ＥＢＶ－ＩｇＭ阳性急性黄疸型肝炎和伴有抗－ＥＢＶ－ＩｇＭ阳性急性黄疸型肝炎（以下称急黄肝）组的主要病情和病程比较：同期诊治不伴有抗－ＥＢＶ－Ｉ
Clinical Significance of Anti-EBV-IgM Detection in Hepatitis Taiyuan Infectious Diseases Hospital (030012) Chen Xiuwei, Wang Xuefang, Xun Jian, Di Xiuzhen, Qi Meimei First Affiliated Hospital of Shanxi Medical College Zhao Longfeng In order to investigate the anti-EBV-IgM in hepatitis The exact meaning of the immune enzyme method we used in patients with acute and chronic hepatitis, anti-EBV-IgM detection and observed in children with anti-FBV-IgM positive group and its negative group of patients with the impact of the disease, the report is now As follows: Materials and Methods January 1990 to January, 955 cases of acute and chronic viral hepatitis in our hospital, 612 cases, 490 cases of adults, children (14 years of age) in 122 cases, admitted to hospital after the blood with immune enzymes Anti-EBV-IgM assay. Reagents by the Chinese Academy of Preventive Medicine Institute of Virology provided hepatitis room. Positive rate of anti-EBV-IgM: In 612 serum samples, anti-EBV-IgM positive 128 cases, accounting for 20.9%, of which 490 cases of adult serum samples, anti-EBV-IgM positive 74 cases 15.1%; 122 cases of pediatric serum samples, anti-EBV-IgM positive in 54 cases, accounting for 44.3%, the positive rate of anti-EBV-IgM in children was significantly higher than that of adults (/2>6.62,P<0 .01). Second, children are not associated with anti-EBV-IgM-positive acute jaundice hepatitis and associated with anti-EBV-IgM positive acute jaundice hepatitis (hereinafter referred to as acute yellow) group of the main disease and course of disease: simultaneous diagnosis and treatment is not associated with anti- -EBV-I